THYAGARAJAN SUBRAMANIAN
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology HERSHEY, PA NPI 1003864091
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology PA Amneal Pharmaceuticals LLC All categories
General Payments — all program years on this page
$293,825.54
- Category: General Payments
- Program years: PY2018–2024
- Record count: 319
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,798.56 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $1,668.00 | 2 |
| Food and Beverage | $130.56 | 6 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amneal Pharmaceuticals LLC | $1,691.24 | 3 |
| UCB, Inc. | $57.13 | 3 |
| Neurocrine BioSciences, Inc. | $31.19 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.00 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1118989502 | Otsuka America Pharmaceutical, Inc. | $19.00 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139203100 | Amneal Pharmaceuticals LLC | $556.00 | 06/13/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1139203102 | Amneal Pharmaceuticals LLC | $1,112.00 | 07/31/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1139203104 | Amneal Pharmaceuticals LLC | $23.24 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143021405 | UCB, Inc. | $25.22 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143021407 | UCB, Inc. | $15.61 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143021409 | UCB, Inc. | $16.30 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150824065 | Neurocrine Biosciences, Inc. | $31.19 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.